PepGen Inc. (PEPG)
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Address
1 MARINA PARK DRIVE, SUITE 900
BOSTON, MA 02210
Founded
2018
Number of Employees
64
Website
http://pepgen.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at PEPG make a trade.
Creating a free account takes less than one minute